Blood clot-targeted nanoparticles

Details Blood clot-targeted nanoparticles Blood clot-targeted nanoparticles

2007-05-22

2007-05-22

Jones, Dameron L. (Department: 1618)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Magnetic imaging agent

C424S009320

Reexamination Certificate

active

10225024

ABSTRACT:
Emulsions comprising nanoparticles formed from high boiling perfluorochemical substances, said particles coated with a lipid/surfactant coating are made target-specific by directly coupling said nanoparticles to a targeting ligand. The nanoparticles may further include biologically active agents, radionuclides, and/or other imaging agents.

REFERENCES:
patent: 5077036 (1991-12-01), Long, Jr.
patent: 5114703 (1992-05-01), Wolf et al.
patent: 5271928 (1993-12-01), Schneider et al.
patent: 5401634 (1995-03-01), Milbrath
patent: 5512294 (1996-04-01), Li et al.
patent: 5536489 (1996-07-01), Lohrmann et al.
patent: 5542935 (1996-08-01), Unger et al.
patent: 5690907 (1997-11-01), Lanza et al.
patent: 5780010 (1998-07-01), Lanza et al.
patent: 5958371 (1999-09-01), Lanza et al.
patent: 6123923 (2000-09-01), Unger et al.
patent: 6139819 (2000-10-01), Unger et al.
patent: 6461586 (2002-10-01), Unger
patent: 6821506 (2004-11-01), Lanza et al.
patent: 4232755 (1994-03-01), None
patent: 0251494 (1988-01-01), None
patent: 0727225 (1996-08-01), None
patent: 0274431 (1998-07-01), None
patent: WO 95/03829 (1995-02-01), None
patent: WO 96/40285 (1996-12-01), None
Flacke et al. “Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques” Circulation 104:1280-1285 (2001).
Hnatowich et al. “Investigation of Avidin and Biotin for Imaging Applications” Journal of Nuclear Medicine 28(8):1294-1302 (1987).
Hudson et al. “Red Cell Volume and Cardiac Output in Anemic Preterm Infants” Archives of Disease in Childhood 65(7):672-675 (1990).
Lanza et al. “Specific Acoustic Enhancement of Vascular Thrombi In Vivo with a Novel Site Targeted Ultrasonic Contrast Agent” Circulation 92(8 Suppl.):1260 (1995).
Lanza et al. “Initial Description and Validation of a Novel Site Targeted Ultrasonic Contrast Agent” Circulation 92 (8 Suppl.):1260 (1995).
Lanza et al. “A Novel Site-Targeted Ultrasonic Contrast Agent with Broad Biomedical Application” Circulation 94(12):3334-3340 (1996).
Lanza et al. “High-Frequency Ultrasonic Detection of Thrombi with a Targeted Contrast System” Ultrasound in Medicine and Biology 23(6):863-870 (1997).
Muzykantov et al. “Immunotargeting of Streptavidin to the Pulmonary Enjdothelium” Journal of Nuclear Medicine 35(8) (1994).
Wallace et al. “Intravascular Ultrasound Detection of Thrombi After Enhancement with a Novel Site Targeted Acoustic Contrast Agent” Circulation 92(8 Suppl.):1585 (1995).

Affiliated with

Also associated with

Rating

Blood clot-targeted nanoparticles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blood clot-targeted nanoparticles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood clot-targeted nanoparticles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3772651